skip to main content
psychiatry & behavioral healthquestionnaire

GAD-7 (Generalized Anxiety Disorder-7)

iatroX editorial team · Updated · Record checked · editorial policy

The GAD-7 is a 7-item self-report questionnaire that screens for generalised anxiety disorder and measures anxiety symptom severity. Each item is scored 0–3 over the past two weeks, with total scores ranging from 0 to 21. It is the most widely used brief anxiety screening tool in primary care.

questionnaire

evidence

derivation

Developed by Spitzer, Kroenke, Williams, and Löwe (2006). Items were selected from a pool of 13 anxiety symptom items using item-response theory and factor analysis in 2,740 primary care patients. The 7-item version was validated against structured psychiatric interview.

validation

Internal consistency: Cronbach's alpha 0.92. At the standard cut-off of ≥10, sensitivity 89% and specificity 82% for generalised anxiety disorder. Good sensitivity also demonstrated for panic disorder (74%), social anxiety disorder (72%), and PTSD (66%). Test-retest reliability (ICC) 0.83. A subsequent meta-analysis by Plummer et al. (2016) confirmed diagnostic accuracy across multiple settings.

guideline endorsements

NICE CG113 (Generalised Anxiety Disorder): recommends GAD-7 or GAD-2 for initial anxiety screening. Widely recommended in IAPT (UK Improving Access to Psychological Therapies) pathways. Used alongside PHQ-9 in routine primary care mental health assessment.

references
  1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.PMID: 16717171
  2. Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274.PMID: 18388841
  3. Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic meta-analysis. Gen Hosp Psychiatry. 2016;39:24-31.PMID: 26719105
  4. NICE Clinical Guideline CG113. Generalised anxiety disorder and panic disorder in adults: management. National Institute for Health and Care Excellence; 2011 (updated 2020).link ↗
Continue exploring

Explore these topics in the iatroX reference and learning libraries.